CXCL12 and breast cancer: Collectively, the inhibition of SOCE demonstrated decreased expression of high salt-induced release of inflammatory cytokine and chemokine, TNF-α and CXCL12, respectively, in the breast cancer cells MCF-7 and MDA-MB-231 (Figure 1C, 1D).